Recent work from this laboratory (1, 2) has demonstrated that mouse resident peritoneal macrophages release the slow-reacting substance (SRS), 1 leukotriene C [5(S)-hydroxy-6(R)- 9, 11, LTC] in response to a phagocytic stimulus. No data are as yet available concerning leukotriene synthesis by other mouse macrophage populations. It is of particular interest to know whether pulmonary macrophages are also able to produce large quantities of leukotrienes because of the sensitivity of the peripheral airways of the lung to SRS (3, 4) . In this report, we present the results of studies of zymosan-induced leukotriene synthesis by mouse pulmonary alveolar macrophages, obtained by bronchoalveolar lavage and by pulmonary interstitial macrophages, isolated by enzymatic digestion of lung tissue.
PTM were isolated from the lung tissue after completion of lavage. The heart and lungs were removed en bloc; the heart, trachea, bronchi, and hilar connective tissue were carefully dissected away. PTM were obtained by mincing the lungs with scissors and incubating the resulting fragments for 60 min at 37°C in Krebs-Ringer phosphate buffer supplemented with 5.4 mM glucose (KRPG) containing trypsin (200 U/ml), collagenase (18 U/ml), and DNAse (140 U/ml). All enzymes were from Worthington Biochemical Corp., Freehold, NJ. The tissue was filtered through sterile gauze, and the cells were washed twice with KRPG. Culture conditions were the same as for PAM except that initial cell suspensions contained 1 × l0 7 cells/ml of medium. Approximately 2.2 :l: 0.2 × 106 adherent cells/60-mm dish were recovered.
In the case of PTM or PAM cultures to be maintained for longer than 24 h, the washed monolayers were treated with trypsin (50 U/ml in a-MEM) at 37°C for 20 min to remove contaminating fibroblasts. The cells were then washed again with buffered saline and overlaid with fresh a-MEM containing 10% serum.
Characterization of Macrophage Populations. Macrophages cultured on glass coverslips were stained for peroxidase by the method of Kaplow (6) and for nonspecific esterase by the method of Li et al. (7) . The phagocytosis of zymosan was quantitated by direct phase contrast microscopy of cells fixed in 2.5% glutaraldehyde following a 60 min exposure to zymosan. Cell viability was assessed by trypan blue exclusion, and cells remained >95% viable throughout all of the experimental procedures.
Release of Arachidonic Acid (20:4) Metabolites by Macrophage Cultures. For the study of 20:4 release and metabolism, macrophages were incubated for 12 h in a-MEM containing 10% serum and 0.5 pCi/ml of [5, 6, 8, 9, 11, 12, 14, 15 -SH]20:4 (sp act 78 Ci/mmol; New England Nuclear, Boston, MA). Unless otherwise stated, cells were labeled immediately after the adherence purification step. After the labeling period, the cells were washed three times with buffered saline and placed in serum-free a-MEM containing 160 #g/ml of unopsonized zymosan (ICN K & K Laboratories, Inc., Plainview, NY) prepared by the method of Bonney et ai. (8) . The cells were then cultured for the designated time periods at 37°C in 95% air/5% CO2 to permit the release of 20:4 metabolites into the culture medium.
Studies of the time course of total 20:4 release by PTM used cells cultured in 15-mm wells. At the end of the culture period with zymosan, the medium was removed and placed in glass scintillation vials for radioactivity measurements. Cell monolayers were washed twice and scraped from the wells into 0.3 ml of a solution of 0.05% Triton X-100 (Rohm and Haas Co., Philadelphia, PA). The wells were scraped again with 0.3 ml of the Triton solution, and the radiolabel content of the cell lysates was determined.
For the characterization of 20:4 metabolites released by macrophages, [aH]20:4-1abeled cultures of PAM or PTM in 60-mm dishes were used. Aliquots (50 pl) of the medium were taken initially for radioactivity measurements, and the cells were then incubated for 4 h in the presence or absence of zymosan. After aliquots were again removed to determine radiolabel content, the medium was placed on ice. The cells were washed and scraped into 0.05% Triton X-100 (2 × 0.75 ml). Portions (100 #1) of the lysates were assayed for radiolabel content, and protein was determined by the method of Lowry et al. (9) .
The 20:4 metabolites in the culture medium were extracted by the method of Unger et al. (10) . Briefly, to 1 ml of medium was added 1 ml ethanol and 10 #1 88% (wt/wt) formic acid, and the resultant solutions were extracted twice with 1 ml of chloroform containing 0.005% (wt/vol) butylated hydroxytoluene (BHT; Sigma Chemical Co., St. Louis, MO). The lower (chloroform) phases were combined, evaporated to dryness under nitrogen, and dissolved in the appropriate starting solvent for further purification by reversed-phase high-pressure liquid chromatography (HPLC). A column of 5 # Ultra.sphere ODS, 4.6 mm × 25 cm (Altex, Rainin Instruments, Woburn, MA) eluted at a flow rate of 1 ml/min was used for all HPLC purifications. Two separate solvent systems were used. System 1 : the first solvent was 60 ml of methanol/water/acetic acid (65:34.9:0.1, vol/vol/vol) adjusted to pH 5.4 with ammonium hydroxide, followed by 40 ml of methanol/acetic acid (100:0.01, vol/vol). System 2: elution was with 120 ml of water:acetonitrile/benzene/aeetic acid (76.7:23:0.2:0.1, vol/vol/vol/vol) followed by 40 ml of methanol/acetic acid (100:0.01, voi/vol). Fractions of 1 ml were collected, and the radiolabel content of whole fractions or aliquots was determined. The elution characteristics of prostaglandins (PG), leukotrienes, monohydroxyeicosatetraenoic acids (mono-HETEs), and unreacted 20:4 were determined by the use of pure radiolabeled standards (see below). Those of di-HETEs and 12-L-hydroxy-5,8,10-heptadecatrienoic acid (HHT) were elucidated by comparison with the corresponding 20:4 metabolites produced by polymorphonuclear leukocytes (11) and platelets (12) , respectively. In addition, the elution of these di-HETEs from the reversed phase HPLC column using methanol/water/acetic acid (75:25:0.01, vol/vol/vol) as the solvent was identical to that reported by others (9-19 min [11] ). Except in the case of LTC, all 20:4 metabolites were identified on the basis of their HPLC elution time.
Purification of Leukotrienes. Chemically pure samples of teukotrienes for ultraviolet or amino acid analysis were obtained from the medium of cells that had been labeled with [3H]20:4 and exposed to zymosan for 4 h. The 20:4 metabolites were extracted from the medium as described above, and the extracts were concentrated under nitrogen. The concentrated extract from ~4 ml of medium was applied in a total volume of 100 #1 of 80% ethanol to a column (0.6 × 10 cm) of activated silicic acid (Silicar CC-7; Mallinckrodt Inc., St. Louis, MO) packed in chloroform (2) .
The columns were eluted sequentially with 5 ml of chloroform, 35 ml of 20% (vol/vol) methanol in chloroform and 20 ml of methanol, all containing 0.005% BHT. The methanol eluates containing the leukotrienes were combined, concentrated under reduced pressure, and rechromatographed as above on a single silicic acid column, with BHT omitted from the eluting solvents. The methanol eluate from this column was concentrated under reduced pressure and subjected to HPLC using system 1.
Amino Acid Analysis of LTC. Fractions from HPLC containing purified LTC were dried
under reduced pressure and hydrolyzed in evacuated ampoules in 6 M HC1 for 20 h at 110°C. Amino acid analysis was performed on a Durrum D-500 automatic amino acid analyzer (Dionex Corp. Sunnyvale, CA) by previously described methods (13, 14) using norleucine as an internal standard.
Bioassay of LTC.
The bioassay for SRS activity was performed using an isolated guinea pig ileum in Tyrode's solution in the presence of atropine (1 #M) and pyrilamine maleate (1/zM), by the method of Chakravarty (15) . One unit of SRS activity was defined as that amount producing a contraction equal to that elicited by 5 ng of histamine.
Macrophage Lipid Extraction, Separation, and Analysis. Macrophages prelabeled for 12 h with
[3H]20:4 were washed, placed in a-MEM with or without zymosan (160 #g/ml), and incubated for 4 h. Aliquots of the medium were taken for radioactivity measurements before and after the 4 h incubation. The cells were washed and scraped into 0.9% saline, and cell lipids were extracted by the procedure of Bligh and Dyer (16) . Concentrated lipid extracts were applied to 0.4-g columns of activated silicic acid (Silicar CC-4; Mallinckrodt Inc.). Neutral lipids and phospholipids were sequentially eluted with 10 ml each of chloroform and methanol, respectively (17) . Fatty acid methyl esters of phospholipids were prepared by transesterification in methanolic HC1 and analyzed by gas-liquid chromatography on 1/8-in X 10-ft columns of 10% SP-2330 on 100/200 Chromosorb WA/W (Supelco, Inc., Bellefonte, PA) at 180°C with a carrier gas flow rate of 30 ml/min (17) .
To determine the localization of [3H]20:4 in individual cell phospholipids, extracts of radiolabeled PTM that had not been exposed to zymosan were subjected to two-dimensional thin-layer chromatography on plates of silica gel (Redi-Coat plates, Supelco, Inc.). To facilitate the visualization of lipid on the plates, phospholipid (0.1/~mol) extracted from unlabeled J774 cells (a macrophage-like cell line) was added to the samples. Plates were developed in the first dimension with chloroform/methanol/ammonium hydroxide (65:35:5, vol/vol/vol) and in the second dimension with chloroform/acetone/acetic acid/methanol/water (30:40:10:10:5, vol/ vol/vol/vol/vol) (18) . The lipid-containing regions were visualized by exposing the plates to iodine vapors, and the silica gel was scraped from the plates into scintillation vials for radioactivity determinations.
Macrophage phospholipid phosphorus content was determined on cell lipid extracts by the method of Ames and Dublin (19) .
Assay of "y-Glutamyl Transpeptidase Activity. Assay solutions contained 0.5 M Tris HCI (pH 8.5), 25 mM glycylglycine, and 2.5 mM L-),-glutamyl-p-nitroanilide (Sigma Chemical Co.). Macrophages cultured in a 60-mm dish were washed twice with buffered saline and overlaid with 1 ml of the reaction solution. After incubation for 6 h at 37°C with gentle agitation, 0.5 ml of the solution was removed and combined with 0.25 ml ice-cold 15% (wt/vol) trichloroacetic acid. The solutions were placed on ice for 15 min, and protein was removed by centrifugation. The optical density was measured at 410 nm after neutralization with solid sodium bicarbonate (20) . One unit of 7-glutamyl transpeptidase activity is defined as 1 pmol of p-nitroaniline produced per hour at 37°C.
Radioactivity Measurements. The radiolabel content of samples was measured by liquid scintillation counting in Hydrofluor (National Diagnostics, Inc., Somerville, N J) using an LKB Ultrobeta 1210 scintillation counter (LKB Instruments, Inc., Rockville, MD). Corrections were made for counting efficiency (---40% for all).
Radiolabeled Standards of 20:4 Metabolites. The recovery of 20:4 metabolites through extraction and purification procedures and their elution times on HPLC were monitored with the aid of radiolabeled standards. [5, 8, 9, 11, 12, 14, 15 -aH]6-ketoPGFt~ (80-120 Ci/mmol), [5, 6, 8, 9, 11, 12, 14, 15 -SH]thromboxane B2 (TXB2, 100-150 Ci/mmol), [9-aH]PGF2, (5-15 Ci/ mmol), and [5, 6, 8, 11, 12, 14, 15 -SH] PGE2 (100-200 Ci/mmol) were purchased from New England Nuclear.
[all] 12-hydroxy-5,8,10,14-eicosatetraenoic acid (12-HETE) and [aH]5-hydroxy-6,8,11,14-eicosatetraenoic acid (5-.I--IETE) were obtained from calcium ionophore A23187stimulated human blood platelets (12) and polymorphonuclear leukocytes (21), respectively, and were the generous gift of Dr. Nicholas Pawlowski of The Rockefeller University.
[aH]LTC was obtained from [aH]20:4-1abeled mouse peritoneal macrophages (1).
[SH]leukotriene D [5(S)hydroxy-6(R)-cysteinylglycyl-7,9,11,14-eicosatetraenoic acid; LTD] was derived from the incubation of [SH]LTC with 7-glutamyltranspeptidase (22) .
[aH]Leukotriene E [5(S)-hydroxy-6(R)-e~steinyl-7,9,11,14-eicosatetraenoie acid; LTE] was similarly obtained as a reaction product of [ H]LTD with leueine aminopeptidase (22) . All leukotrienes were purified by silicic acid column chromatography and HPLC as described above. Standards were dissolved in a-MEM from cultures of unlabeled macrophages challenged with zymosan for extraction and HPLC purification.
Results
Mouse Pulmonary Macrophage Populations. Two macrophage populations were obtained from lungs on the basis of their accessibility to lavage. PAM were readily obtained by washing the tracheo-bronchial tree five times with saline, whereas PTM included those cells remaining in the alveoli after the lavage in addition to interstitial macrophages. The cytochemical and phagocytic properties of the two cell populations as well as cell recoveries are summarized in Table I . These data indicate that typical macrophages comprised at least 80 and 95% of PTM and PAM populations, respectively. layer chromatography of PTM lipid extracts indicated that ~40% of the aH was localized in phosphatidylcholine, whereas phosphatidylethanolamine, phosphatidylinositol, and phosphatidylserine contained 23, 16, and 7%, respectively. The remaining 14% was recovered from neutral lipid. Less than 1% of the cell-associated radiolabel was present as the free fatty acid. Synthesis of L TC by PTM and PAM. Initial studies of the radiolabeled products released by [aH]20:4-1abeled PTM indicated that LTC was a major 20:4 metabolite of these cells. This metabolite was subsequently purified from PTM culture medium by extraction, silicic acid column chromatography, and HPLC (Fig. 2) . A peak of radioactivity was obtained from HPLC, which co-migrated with LTC isolated from mouse peritoneal macrophages (elution time = 19 min). The ultraviolet spectrum of this material (Fig. 2) indicated an absorption maximum at 280 nm with shoulders at 270 nm and 292 nm, confirming the presence of a conjugated triene structure. Amino acid analysis yielded 0.82 nmol of glutamic acid and 1.0 nmol of glycine per nanomole of leukotriene as determined by absorbance at 280 nm (¢ = 40,000 [23] ). Other amino acids, including cysteine, were recovered at <0.1 nmol/nmol leukotriene. This result was consistent with the structure of LTC, but not of LTD or LTE. The failure to quantitatively recover cysteine in acid hydrolysates of leukotrienes has been reported by others (23) . Bioassay of the 20:4 metabolite in a standard guinea pig ileum preparation (Fig. 2) Leukotriene synthesis was also studied in parallel PAM cultures. As in the case of PTM, LTC was the major ieukotriene synthesized by PAM; however, small quantities of two other 3H-labeled metabolites were isolated from PAM culture medium. These have been tentatively identified as LTD and LTE on the basis of co-migration with radiolabeled standards on HPLC (Fig. 2 synthesized by zymosan-challenged PTM and PAM using HPLC system 1, which allows the mutual separation of cyclo-oxygenase and lipoxygenase products. A representative chromatogram for PTM cultures is shown in Fig. 3 . In profiles from both PTM and PAM cultures, LTC was evident as a prominent peak of radiolabel (elution time = 19 min) together with significant quantities of cyclo-oxygenase products that constitute the major radiolabeled species in the peak eluting at 4-15 min. Minor amounts of HETEs and unreacted 20:4 were also evident, as were, in the case of PAM, small peaks of LTD (35 min) and LTE (46 min). Separation of the individual cyclo-oxygenase products formed by pulmonary macrophages using HPLC system 2 indicated that both PAM and PTM formed TXA2 (isolated as TXB2) and PGE~. In addition, PTM, but not PAM, synthesized low levels of prostacyclin (isolated as 6- keto-PGFla) (Fig. 4) . The specific release of all 20:4 metabolites was calculated from radiolabel data and is expressed in Table II as percent of total 20:4 release obtained after zymosan treatment. It is evident that lipoxygenase products (LTC and HETEs) represent the major portion of the identified 20:4 metabolites of these cells.
Uptake of [aH]20:4 by Pulmonary Macrophages and Its Distribution in

Release of [~H
Alterations in PTM Phospholipids with Phagocytosis. Direct fatty acid analysis indi-
cated that the phagocytosis of zymosan was associated with a 15% reduction in the 20:4 content of PTM phospholipid (Table III) . This value was in good agreement with the specific release (zymozan-treated cultures -control cultures) of aH from the cells, which indicated a loss of 14% of the phosphofipid' radiolabel. In a second experiment, values for specific release of phospholipid 20:4 were 10% from fatty acid analysis and 12% from radiolabel data.
PTM cultures contained 302 :t 18 pmol of phospholipid/#g cell protein, a value that did not change with phagocytosis (295 :t: 5 pmol/gg cell protein). Therefore, the 20:4 content of PTM was 140 pmol/gg cell protein, and a specific release of 11% of phospholipid [SH]20:4 represented a loss of 15 pmol of 20:4/#g cell protein.
Discussion
In these studies, we have examined 20:4 metabolism in two mouse pulmonary macrophage populations. These include PAM, which were obtained by lavage of the airways, and PTM, which were isolated by enzymatic digestion. Of the two cell populations, PTM released greater quantities (two-to threefold) of 20:4 metabolites than did PAM under identical culture conditions. Because the PTM cultures were undoubtedly a mixture of interstitial and alveolar macrophages of unknown proportions, it is possible that the capacity of the pulmonary interstitial macrophage to release 20:4 metabolites is actually greater than indicated by the data for PTM. The differences in 20:4 release observed between PTM and PAM populations did not appear to result from the use of proteolytic enzymes to isolate PTM, because exposure of PAM to these enzymes did not alter the zymosan-induced 20:4 release by those cells. Recent studies by Bluss~ Van Oud Alblas and Van Furth (5) have suggested that alveolar macrophages originate as pulmonary interstitial macrophages which, in turn, are derived from blood monoeytes. Once in the alveolar space, the macrophages are continually exposed to foreign particulate matter and are very actively phagocytic. It is possible that this constant stimulation of macrophages in the alveoli results in changes in the cells that are accompanied by a down regulation of 20:4 metabolism as observed in PAM cultures.
The release of 20:4 in response to zymosan decreased with culture time in both PTM and PAM populations. Treatment of 60-h PTM cultures with the proteolytic enzymes used for their isolation failed to restore 20:4 release to levels observed in 12-h cultures, which indicates that these changes were not an artifact of the isolation procedure. Furthermore, time in culture did not affect 20:4 release in response to calcium ionophore A23187. It has been suggested that unopsonized zymosan interacts * Cultures of PTM were incubated for 4 h in the presence or absence of unopsonized zymosan (160 #g/ml). The cells were then washed and scraped into isotonic saline. The fatty acid content of isolated phospholipids was determined by gas-liquid chromatography after transesterification. :~ Each value is the mean 3= SD of four chromatographic analyses of a single sample.
with the macrophage membrane by binding to the receptor for mannose-terminal glycoproteins (25) . Preliminary studies also indicated that 20:4 metabolism stimulated by opsonized zymosan and immune complex-coated Sephadex beads decreases with time. These observations suggest that an alteration in receptor-mediated 20:4 metabolism occurs in cultured pulmonary macrophages. Spectroscopic quantitation of purified [aH]LTC obtained from radiolabeled PTM cultures indicated that its specific activity (69 dpm/pmol LTC) was in good agreement with that of the total cell phospholipid 20:4 (70 dpm/pmol 20:4). Furthermore, fatty acid analysis indicated that the release of 3H from cell phospholipid provided an accurate measurement of the 20:4 released by the cells in response to zymosan. Similar results were obtained in [3H]20:4-1abeled mouse resident peritoneal macrophages, which were also shown to release [aH]PGE2 having a specific activity equivalent to that of the total phospholipid 20:4 pool (1, 26). These considerations indicate that the specific activity of the [aH]20:4 in macrophage phospholipids may be used to calculate molar quantities of isolated 20:4 metabolites from their radiolabel content. In Table  IV are the results of such calculations for the 20:4 metabolites of PTM. Also included are corresponding values for resident peritoneal macrophages cultured under similar conditions, providing a direct comparison of two macrophage populations from distinct body sites in a single species. Both PTM and peritoneal macrophages are rich sources of 20:4 metabolites; however, there are differences in the proportions of the released 20:4 that is metabolized by the cyclo-oxygenase and lipoxygenase pathways. Lipoxygenase products predominate in PTM 20:4 metabolites and LTC is the single major compound. In contrast, peritoneal macrophages secrete relatively more cyclooxygenase products, with PGE~ predominating.
The finding that pulmonary macrophages are rich sources of LTC suggests that these cells may play a role in inflammatory or immunologic reactions that result in SRS formation in the lung. Considerable work in the past has shown that specific antigen challenge of IgE-sensitized lung tissue results in significant SRS production; however, studies of purified pulmonary mast cells have indicated that these cells are not capable of releasing large quantities of leukotrienes (27, 28) . The possibility must therefore be considered that the macrophage is the source of SRS in these IgEmediated reactions. The present studies demonstrate LTC production in response to phagocytic stimuli, and, at present, macrophage 20:4 metabolism in response to IgE and antigen has not been reported. However, the binding of IgE to the macrophage membrane as well as cell-cell interactions between mast ceils and mononuclear phagocytes have been suggested as possible mechanisms for the stimulation of LTC release by macrophages (28, 29) . The synthesis of LTC by pulmonary macrophages in response to phagocytic stimuli raises other questions concerning the possible involvement of SRS generation during acute and chronic inflammatory states. The recently reported vascular effects of LTC and LTD suggest that these substances are potent proinflammatory agents (30) . Thus, it is likely that the role of SRS formation in the lung is not limited to immediate hypersensitivity reactions.
Summary
Mouse resident pulmonary macrophages were subdivided into alveolar (PAM) and interstitial (PTM) populations on the basis of accessibility to pulmonary lavage, and zymosan-induced arachidonic acid (20:4) metabolism was examined in both populations labeled with [3H]20:4. Maximal phagocytic doses of unopsonized zymosan induced the specific release of 11% of phospholipid 20:4 by PTM and 4.6% by PAM. Direct fatty acid analysis of [3H]20:4-1abeled PTM cultured in the presence or absence of zymosan indicated that the specific activity of the [ZH]20:4 in cell phospholipid provided an accurate measure of 20:4 released by the cells, and could therefore be used to quantitate the synthesis of 20:4 metabolites by PTM in vitro. The single major 20:4 metabolite of PTM was the slow-reacting substance leukotriene C, which was synthesized in quantities of 3-4 pmol//~g cell protein (280-370 pmol/10 ~ cells), and comprised 20-25% of the released 20:4. PTM also synthesized prostaglandin Ez, prostacyclin, thromboxane A2, and hydroxyeicosatetraenoic acids. In contrast, PAM produced leukotrienes D and E in addition to leukotriene C, prostaglandin E2, thromboxane A2, and hydroxyeicosatetraenoic acids. Prostacyclin formation by PAM was not observed. These studies define a set of experimental conditions for the study of 20:4 metabolism by pulmonary macrophages, and demonstrate that these cells are rich sources of LTC as well as other 20:4 oxygenated products.
